These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 21538030

  • 1. Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.
    Tan VP, Wong WM, Cheung TK, Lai KC, Hung IF, Chan P, Pang R, Wong BC.
    J Gastroenterol; 2011 Jul; 46(7):906-12. PubMed ID: 21538030
    [Abstract] [Full Text] [Related]

  • 2. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [Abstract] [Full Text] [Related]

  • 3. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [Abstract] [Full Text] [Related]

  • 4. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [Abstract] [Full Text] [Related]

  • 5. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.
    Niu XP, Yu BP, Wang YD, Han Z, Liu SF, He CY, Zhang GZ, Wu WC.
    World J Gastroenterol; 2013 May 28; 19(20):3124-9. PubMed ID: 23716993
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial.
    Chiang HH, Wu DC, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Yao CC, Tsai CE, Liang CM, Wang YK, Wang JW, Huang CF, Chuah SK, Taiwan Acid-Related Disease Study Group.
    Drug Des Devel Ther; 2019 May 28; 13():1347-1356. PubMed ID: 31118571
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T, Harada K, Hatta H, Tokura T, Oshiro Y, Nishizaki T, Obata T, Mori M, Fueki T, Fujimoto S, Haruna Y, Kuwabara A, Yorimitsu D, Ihoriya C, Kadoya H, Itano S, Fujimoto Y, Komai N, Sasaki T, Kashihara N.
    Clin Exp Nephrol; 2016 Feb 28; 20(1):134-42. PubMed ID: 26026991
    [Abstract] [Full Text] [Related]

  • 9. Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Sakurai K, Suda H, Fujie S, Takeichi T, Okuda A, Murao T, Hasuda K, Hirano M, Ito K, Tsuruta K, Hattori M.
    Dig Dis Sci; 2019 Mar 28; 64(3):815-822. PubMed ID: 30415407
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of esomeprazole for treatment of poorly controlled asthma.
    American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA.
    N Engl J Med; 2009 Apr 09; 360(15):1487-99. PubMed ID: 19357404
    [Abstract] [Full Text] [Related]

  • 11. GERD assessment including pH metry predicts a high response rate to PPI standard therapy.
    Kandulski A, Peitz U, Mönkemüller K, Neumann H, Weigt J, Malfertheiner P.
    BMC Gastroenterol; 2013 Jan 16; 13():12. PubMed ID: 23324360
    [Abstract] [Full Text] [Related]

  • 12. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    BMC Pediatr; 2010 Jun 11; 10():41. PubMed ID: 20540767
    [Abstract] [Full Text] [Related]

  • 13. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.
    Am J Gastroenterol; 2001 Jan 11; 96(1):27-34. PubMed ID: 11197282
    [Abstract] [Full Text] [Related]

  • 14. Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial.
    Boltin D, Zvidi I, Raskin M, Kayless H, Schmilovitz-Weiss H, Gingold-Belfer R, Niv Y, Dickman R.
    Dig Dis; 2018 Jan 11; 36(4):257-263. PubMed ID: 29791895
    [Abstract] [Full Text] [Related]

  • 15. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P, Staniak A, Grzegrzolka J.
    J Comp Eff Res; 2016 Mar 11; 5(2):169-78. PubMed ID: 26946951
    [Abstract] [Full Text] [Related]

  • 16. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F, Hashiguchi K, Onitsuka Y, Tanigawa K, Minami H, Matsushima K, Akazawa Y, Shiozawa K, Yamaguchi N, Taura N, Ohnita K, Ichikawa T, Isomoto H, Nakao K.
    Med Sci Monit; 2015 Dec 31; 21():4111-21. PubMed ID: 26719012
    [Abstract] [Full Text] [Related]

  • 17. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL, Nie YQ, Hou XH, Xie PY, Fang JY, Yuan YZ, Zhou LY, Zhao NQ, Chen MH.
    J Dig Dis; 2013 Sep 31; 14(9):463-8. PubMed ID: 23659834
    [Abstract] [Full Text] [Related]

  • 18. Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.
    Fock KM, Teo EK, Ang TL, Chua TS, Ng TM, Tan YL.
    World J Gastroenterol; 2005 May 28; 11(20):3091-8. PubMed ID: 15918196
    [Abstract] [Full Text] [Related]

  • 19. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P, van Zanten SV, Mattsson H, Wernersson B.
    Aliment Pharmacol Ther; 2012 Oct 28; 36(7):635-43. PubMed ID: 22860764
    [Abstract] [Full Text] [Related]

  • 20. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
    Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N, Eklund S.
    BMC Gastroenterol; 2016 Apr 14; 16():48. PubMed ID: 27080034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.